Borg-von Zepelin M - Search Results

1

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.

Gruber A, Speth C, Lukasser-Vogl E, Zangerle R, Borg-von Zepelin M, Dierich MP, Würzner R. Gruber A, et al. Immunopharmacology. 1999 Apr;41(3):227-34. doi: 10.1016/s0162-3109(99)00035-1. Immunopharmacology. 1999. PMID: 10428651

2

Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro.

Falkensammer B, Pleyer L, Ressler S, Berg A, Borg-von Zepelin M, Nagl M, Lass-Flörl C, Speth C, Dierich MP, Würzner R. Falkensammer B, et al. Among authors: borg von zepelin m. Mycoses. 2008 Nov;51(6):505-14. doi: 10.1111/j.1439-0507.2008.01515.x. Epub 2008 Apr 16. Mycoses. 2008. PMID: 18422912 Free PMC article.

3

Gruber A, Berlit J, Speth C, Lass-Flörl C, Kofler G, Nagl M, Borg-von Zepelin M, Dierich MP, Würzner R. Gruber A, et al. Immunobiology. 1999 Sep;201(1):133-44. doi: 10.1016/S0171-2985(99)80052-7. Immunobiology. 1999. PMID: 10532286

4

Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro.

Gruber A, Lukasser-Vogl E, Borg-von Zepelin M, Dierich MP, Würzner R. Gruber A, et al. J Infect Dis. 1998 Apr;177(4):1057-63. doi: 10.1086/515231. J Infect Dis. 1998. PMID: 9534982

5

HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.

Borg-von Zepelin M, Meyer I, Thomssen R, Würzner R, Sanglard D, Telenti A, Monod M. Borg-von Zepelin M, et al. J Invest Dermatol. 1999 Nov;113(5):747-51. doi: 10.1046/j.1523-1747.1999.00747.x. J Invest Dermatol. 1999. PMID: 10571729 Free article.

6

HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro.

Bektić J, Lell CP, Fuchs A, Stoiber H, Speth C, Lass-Flörl C, Borg-von Zepelin M, Dierich MP, Würzner R. Bektić J, et al. FEMS Immunol Med Microbiol. 2001 Jul;31(1):65-71. doi: 10.1111/j.1574-695X.2001.tb01588.x. FEMS Immunol Med Microbiol. 2001. PMID: 11476984 Free article.

7

Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients.

Ollert MW, Wende C, Görlich M, McMullan-Vogel CG, Borg-von Zepelin M, Vogel CW, Korting HC. Ollert MW, et al. J Clin Microbiol. 1995 Oct;33(10):2543-9. doi: 10.1128/jcm.33.10.2543-2549.1995. J Clin Microbiol. 1995. PMID: 8567880 Free PMC article.

8

In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients.

Schaller M, Hube B, Ollert MW, Schäfer W, Borg-von Zepelin M, Thoma-Greber E, Korting HC. Schaller M, et al. J Invest Dermatol. 1999 Mar;112(3):383-6. doi: 10.1046/j.1523-1747.1999.00525.x. J Invest Dermatol. 1999. PMID: 10084319 Free article.

9

The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages.

Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M. Borg-von Zepelin M, et al. Mol Microbiol. 1998 May;28(3):543-54. doi: 10.1046/j.1365-2958.1998.00815.x. Mol Microbiol. 1998. PMID: 9632257 Free article.

10

The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.

Monod M, Borg-von Zepelin M, Telenti A, Sanglard D. Monod M, et al. Dermatology. 1999;198(4):412-4. Dermatology. 1999. PMID: 10490300 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters